Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chu-Chiao Wu

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Structure (London, England : 1993)|January 12, 2011
DARK apoptosome secrets come to lightChu-Chiao Wu, Shawn B Bratton
Antioxidants & Redox Signaling|September 18, 2012
Regulation of the intrinsic apoptosis pathway by reactive oxygen speciesChu-Chiao Wu, Shawn B Bratton
Molecular & Cellular Oncology|April 13, 2017
Caspase-9 swings both ways in the apoptosomeChu-Chiao Wu, Shawn B Bratton
International Journal of Radiation Biology|January 6, 2011
Inactivation of ataxia telangiectasia mutated gene can increase intracellular reactive oxygen species levels and alter radiation-induced cell death pathways in human glioma cellsShu-Chi Wang, Chu-Chiao Wu, Yuan-Yaw Wei, et al.
Nature Communications|November 25, 2016
The Apaf-1 apoptosome induces formation of caspase-9 homo- and heterodimers with distinct activitiesChu-Chiao Wu, Sunhee Lee, Srinivas Malladi, et al.
International Journal of Molecular Sciences|June 26, 2025
Onvansertib-Based Second-Line Therapies in Combination with Gemcitabine and Carboplatin in Patient-Derived Platinum-Resistant Ovarian CarcinomasFederica Guffanti, Ilaria Mengoli, Francesca Ricci, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 30, 2024
Onvansertib in Combination With Chemotherapy and Bevacizumab in Second-Line Treatment of <i>KRAS</i>-Mutant Metastatic Colorectal Cancer: A Single-Arm, Phase II TrialDaniel H Ahn, Maya Ridinger, Timothy L Cannon, et al.
Journal of Medicinal Chemistry|September 18, 2025
Identification of VVD-214/RO7589831, a Clinical-Stage, Covalent Allosteric Inhibitor of WRN Helicase for the Treatment of MSI-High CancersShota Kikuchi, Jason C Green, Don C Rogness, et al.
Nature|July 3, 2024
Author Correction: Chemoproteomic discovery of a covalent allosteric inhibitor of WRN helicaseKristen A Baltgalvis, Kelsey N Lamb, Kent T Symons, et al.
Nature|April 24, 2024
Chemoproteomic discovery of a covalent allosteric inhibitor of WRN helicaseKristen A Baltgalvis, Kelsey N Lamb, Kent T Symons, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Structure (London, England : 1993)|January 12, 2011
DARK apoptosome secrets come to lightChu-Chiao Wu, Shawn B Bratton
Antioxidants & Redox Signaling|September 18, 2012
Regulation of the intrinsic apoptosis pathway by reactive oxygen speciesChu-Chiao Wu, Shawn B Bratton
Molecular & Cellular Oncology|April 13, 2017
Caspase-9 swings both ways in the apoptosomeChu-Chiao Wu, Shawn B Bratton
International Journal of Radiation Biology|January 6, 2011
Inactivation of ataxia telangiectasia mutated gene can increase intracellular reactive oxygen species levels and alter radiation-induced cell death pathways in human glioma cellsShu-Chi Wang, Chu-Chiao Wu, Yuan-Yaw Wei, et al.
Nature Communications|November 25, 2016
The Apaf-1 apoptosome induces formation of caspase-9 homo- and heterodimers with distinct activitiesChu-Chiao Wu, Sunhee Lee, Srinivas Malladi, et al.
International Journal of Molecular Sciences|June 26, 2025
Onvansertib-Based Second-Line Therapies in Combination with Gemcitabine and Carboplatin in Patient-Derived Platinum-Resistant Ovarian CarcinomasFederica Guffanti, Ilaria Mengoli, Francesca Ricci, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 30, 2024
Onvansertib in Combination With Chemotherapy and Bevacizumab in Second-Line Treatment of <i>KRAS</i>-Mutant Metastatic Colorectal Cancer: A Single-Arm, Phase II TrialDaniel H Ahn, Maya Ridinger, Timothy L Cannon, et al.
Journal of Medicinal Chemistry|September 18, 2025
Identification of VVD-214/RO7589831, a Clinical-Stage, Covalent Allosteric Inhibitor of WRN Helicase for the Treatment of MSI-High CancersShota Kikuchi, Jason C Green, Don C Rogness, et al.
Nature|July 3, 2024
Author Correction: Chemoproteomic discovery of a covalent allosteric inhibitor of WRN helicaseKristen A Baltgalvis, Kelsey N Lamb, Kent T Symons, et al.
Nature|April 24, 2024
Chemoproteomic discovery of a covalent allosteric inhibitor of WRN helicaseKristen A Baltgalvis, Kelsey N Lamb, Kent T Symons, et al.
Pageof 1